Revascular adds $3M to clear arteries
Revascular Therapeutics, maker of a device that helps doctors clear blockages in major arteries, has tacked on $3 million to a second round of funding, bringing its total to $11 million, reports VentureWire. The Sunnyvale, Calif., company hopes to add $1 million more to fully fund a study on its lead product.
Revascular’s device — which combines light and sound to guide physicians through vein-clearing procedures — is under testing in Europe expected to finish in June or July. After that, the company will submit it to the Food and Drug Administration for approval. It is currently looking for a distribution or acquisition deal to take the product commercial.
The newest funding came from Adams Street Partners, Bio-Star Equity Fund, Charter Life Sciences and Latterell Venture Partners. The company, which doesn’t have a web site, has now raised $14.5 million to date.
Next Story: Horsley Bridge closes $1.5B fund of funds
Previous Story: Twitscoop tracks live Twitter buzz, playfully and powerfully
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.